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Maitotoxin is the most potent of the known marine toxins. The effect of maitotoxin on muscle contraction 
or hormone release was consistent with its action on the voltage-sensitive channel. Indeed, calcium antago- 
nists such as nifedipine or diltiazem were able to reverse the maitotoxin effects. Using smooth muscle cells, 
we have analysed the effects of maitotoxin on the inositol phosphate metabolism. Maitotoxin stimulates 
the inositol phosphate formation (5 f 1.8-fold in the presence of 10 mM LiCl). Moreover, this effect is 
not reversed, even partially by calcium antagonists, by tll antagonists and is not mimicked by CaZ+ iono- 
phores such as A23187 or calcium agonists such as Bay-K 8644. The action of maitotoxin is further dis- 
cussed in this paper. 
Maitotoxin Polyphosphoinositide Myocyte (Rat aorta) 
1. INTRODUCTION 
Ciguatera, a food poisoning caused by the inges- 
tion of tropical reef fish, is a grave nutritional 
problem in certain Pacific archipelagoes. Further- 
more, several cases of ciguatera have recently been 
reported in France due to the consumption of 
deep-frozen fish of tropical origin [l]. The toxic 
compounds responsible for these intoxications, 
CTX and MTX, are produced by the dinoflagellate 
Gambierdiscus toxicus and are transmitted to the 
tropical reef fish via their normal food chain. CTX 
appears to increase the sodium permeability [2] of 
Abbreviations: CTX, ciguatoxin; MTX, maitotoxin; 
WCC, voltage-sensitive calcium channel; IPI, IPz, IP3, 
the mono-, bis- and trisphosphates of inositol; IP, ino- 
sitol phosphate 
plasma membranes, whereas MTX, the most po- 
tent of the known marine toxins, may stimulate the 
opening of the VSCCs. While the effects of MTX 
on Ca2+ fluxes and other Ca2+-dependent 
phenomena (e.g., muscle contraction [3-71 or hor- 
mone release [8-l 11) are consistent with its alleged 
action at the VSCCs, there may be another equally 
valid explanation for its mechanism of action. It 
has recently been shown that inositol 1,4,5-tris- 
phosphate (IP3) liberates Ca2+ from intracellular 
storage sites [12] and thus stimulates Ca2+- 
dependent phenomena such as the elevation of the 
fertilization membranes of sea urchin [13] and 
starfish [14] oocytes. We therefore examined the 
effect of MTX on the metabolism of IPs and 
found that this toxin is a very potent stimulus for 
formation of IPs. This study suggests that in 
myocytes MTX elevates the level of IPs, possibly 
through a direct action on the metabolism of IPs. 
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2. MATERIALS AND METHODS 
2.1. Preparation of aortic myocytes 
Aortic myocytes were prepared from adult male 
rat aortic medias as described [151. Briefly, aortae 
were dissected from lZweek-old male Wistar rats 
and digested for 30 min by treatment with col- 
lagenase. After elimination of the adventitia and 
the endothelium, the myocytes were disaggregated 
by incubating them in a collagenase-elastase mix- 
ture for 90 min. The separated myocytes were 
grown on collagen-coated micro-carriers while be- 
ing stirred for 13-14 days in modified Eagle’s 
medium (MEM) supplemented with vitamins, 
amino acids and 5% foetal calf serum. 
2.2. Preparation of maitotoxin 
MTX was purified from a methanol extract of 
Gambierd~scus toxicus as described [S]. 
2.3. Measurement of phosphotH]inositide 
hydrolysis 
Cells were preincubated for 2 days in culture 
medium complemented with 2.5 &i/ml myo- 
f3H]inositol. Ceils were then washed 3 times with 
a PBS buffer (composition in mM: 138 NaCl, 2.7 
KCI, 8 NazHP04, 1.5 KH~P04,0.5 MgClz and 0.9 
CaCl2) and distributed in test tubes. After MTX 
stimulation, the reaction was stopped by adding 
4OOyl of 10% PCA. ‘H-labelled myo-inositol- 
phosphates were extracted and separated by ion- 
exchange chromatography (Dowex l-10, formate 
form, 100-200 mesh) as described [16]. 
3. RESULTS AND DISCUSSION 
Rat aortic myocytes were used f3- 16 days after 
seeding. 3-4 days prior to the experiment the 
culture medium was supplemented with 
2.5 &i/ml of myo-[3H]inositol. Cells were prein- 
cubated for 10 min in PBS medium containing 
10 mM LiCl and then exposed for 45 min to MTX. 
MTX stimulated IP formation in a dose dependent 
manner (fig.1). The magnitude of the MTX-in- 
duced response saturated at 5 t l&fold the basal 
level determined in the absence of MTX. The ECse 
(3.25 x lo-l0 + 0.83 g/ml; n = 3) for the ac- 
cumulation of 1P was similar to the apparent EC& 
found for the MTX-induced contraction of rabbit 
aorta [4] and intestinal smooth muscle [7] and even 
01 o+ -11 I -10 -9 -8 * 
log I MTX I @'ml) 
Fig. 1. Dose response curve of maitotoxin. After two 
washings with a PBS buffer (as described in section 2), 
the cells were distributed in test tubes and incubated for 
10 min with 1 ml PBS buffer supplemented with 10 mM 
LICI. Increasing concentrations of MTX were added and 
the reaction was stopped after 45 min by adding 400pl 
of 10% PCA. The IPs were extracted and separated as 
described under section 2. Data shown are the means, 
expressed as a percentage of the response induced by 
lo-’ g/ml MTX, + SE of triplicate determinations and 
are representative of 3 such studies. 
lower than that found for the MTX-induced 
release of hormones [9, lo]. Since our primary 
culture system appears to be free of fibroblasts, 
epithelial cells and nerve endings, the origin of this 
MTX-induced formation of IP can be attributed 
solely to the cultured myocytes. 
It is now generally accepted that the first step in 
the phosphatidylinositol (PI) response is the 
degradation of phosphatidylinositol-4,5-bisphos- 
phate (PIP2) into two second messenger molecules, 
diacylglycer~l (DAG), which activates the protein 
kinase C [17], and IPs, which liberates Ca2+ from 
/ntracellular Ca*+ pools [12]. IP3 should therefore 
be the first IP generated whereas IPz and IPi are 
considered to be degradation products of IP3. The 
results of studies on the kinetics of IP formation in 
the absence of LiCl are shown in fig.2 and are con- 
sistent with this model, Upon MTX stimulation the 
accumulation of IP3 did not show a marked lag 
period. The rate of IP3 accumulation was either 
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Fig.2. Time course of MTX-induced IPi, IPz, and IPs 
formation in the absence of LiCl. 10-s g MTX (0) or 
buffer (0) was added at time 0 and the formation of 
IPi, IP2 and IPs was measured at the indicated time 
points after the MTX addition. Values were significantly 
different (x, p I 0.05; xx, p 5 0.01; xxx, p s 0.005) from 
control as determined by Student’s t-test. 
equivalent to or greater than the rates of MTX- 
induced Ca2+ uptake reported in various cell types 
[8,10,18]. 
The hypothesis that MTX stimulates the opening 
of Ca2+ channels is based mainly on the fact that 
Ca2+ channel antagonists can inhibit the MTX- 
induced responses [4,8,11]. However, in our 
system neither nifedipine (10m6 M), diltiazem 
(10m5 M) nor verapamil (10e5 M) significantly 
depressed the MTX-stimulated IP response (fig.3). 
Furthermore, neither the Ca2+ channel agonist 
Bay-K 8644 nor the Ca2+ ionophore A23 187 was 
able to mimic this action of MTX. Our results ob- 
tained with drugs acting on VSCCs argue against 
the possibility that the MTX-induced IP formation 
is a consequence of Ca2+ influx through VSCCs. 
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Fig.3. Effect of cu-adrenergic and Ca2+ channel 
antagonists on MTX-induced IP formation and the 
effect of Bay-K 8644 and A23187 on the level of IP. 
Cells were incubated with prazosin (PRA), 
phentolamine (PHE), nifedipine (NI), diltiazem (DIL) 
and verapamil (VER) at the indicated concentrations, 
15 min prior to stimulation with IO-’ g/ml of MTX. 
The formation of IPs was measured as described in 
section 2. Results are the means of 3 independent 
experiments and are expressed as the percentage of the 
response induced by lo-* g MTX. 10m6 M Bay-K 8644 
and 2 x 10e6 M A23187 were added after preincubation 
of the cells with LiCl. The experiments with Bay-K 8644 
were done in a high K+ (15 mM) PBS buffer. At this 
potassium concentration, 10e6 M Bay-K 8644 was 
shown to induce a maximal contraction of the isolated 
rabbit aorta [20]. Results are the means, expressed as a 
percentage of the response induced by 10m8 g/ml MTX, 
f SE of at least 3 independent experiments on separate 
culture preparations, performed in triplicates. 
Moreover, the A23187 data suggest that this 
response is not consequent o an increase in in- 
tracellular Ca2+ levels due to other unforeseen ef- 
fects of MTX on the Ca2+ permeability of the 
plasma membrane. As already studied in model 
systems [9], MTX does not present any 
ionophoretic activity. Therefore, it is unlikely that 
the IP stimulation is a consequence of Ca2+ entry 
in the cell. However, it is uncertain whether the 
Ca2+ influx is due to the stimulation of IPs or if the 
two events are independent. 
The fact that Ca2+ channel blockers inhibit the 
MTX-induced contractile response in smooth mus- 
cle preparations [4,8] does not prove that MTX in- 
teracts directly with Ca2+ channels. In fact, the 
MTX-induced contraction in these tissues may 
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result from its action at more than one locus. We 
demonstrate here that one effect of MTX might be 
the direct stimulation of IP formation. Based on 
the data presented here it is reasonable to 
hypothesize that one way MTX may stimulate 
smooth muscle contraction is via the triggering of 
IP formation. 
However, it has previously been found that 
10m6 M phentolamine (PHE) [4] and 10m6 M 
prazosin (PRA) (N. Vidal and J. Haiech, un- 
published), both cu-adrenergic antagonists, partly 
inhibit the MTX-induced arterial contractile 
response. The same concentration of these drugs 
did not affect the IP formation in our system 
(fig.3). One explanation for this difference is that 
the fraction of the contractile response of rabbit 
aorta blockable by cu-adrenergic antagonists could 
be due to noradrenaline release from remaining 
nerve endings in this tissue preparation. 
Earlier work [ 191, done with cu-latrotoxine, gave 
similar results and also favoured the hypothesis 
that such toxins may act on intracellular Ca2+ con- 
centration through stimulation of IP metabolism. 
MTX appears to bind on a finite number of high 
affinity sites, the nature of which will have to be 
defined in order to understand better the 
mechanism of action of these toxins. 
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